Phase I Study Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck.

Trial Profile

Phase I Study Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Oct 2017

At a glance

  • Drugs Panitumumab (Primary) ; Carboplatin; Cisplatin; Docetaxel; Fluorouracil; Paclitaxel
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 06 Mar 2012 Planned end date changed from 1 Apr 2010 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 09 Oct 2009 Planned end date changed from Apr 2009 to Apr 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top